DE69231473D1 - Immunochemischer nachweiss von endprodukten der fortgeschrittenen glycosylation in vivo - Google Patents
Immunochemischer nachweiss von endprodukten der fortgeschrittenen glycosylation in vivoInfo
- Publication number
- DE69231473D1 DE69231473D1 DE69231473T DE69231473T DE69231473D1 DE 69231473 D1 DE69231473 D1 DE 69231473D1 DE 69231473 T DE69231473 T DE 69231473T DE 69231473 T DE69231473 T DE 69231473T DE 69231473 D1 DE69231473 D1 DE 69231473D1
- Authority
- DE
- Germany
- Prior art keywords
- advanced glycosylation
- disclosed
- age
- vivo
- glycosylation endproducts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/723—Glycosylated haemoglobin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81157991A | 1991-12-20 | 1991-12-20 | |
US07/956,849 US5624804A (en) | 1991-12-20 | 1992-10-01 | Immunochemical detection of In vivo advanced glycosylation end products |
PCT/US1992/011158 WO1993013421A1 (en) | 1991-12-20 | 1992-12-21 | Immunochemical detection of in vivo advanced glycosylation endproducts |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231473D1 true DE69231473D1 (de) | 2000-10-26 |
DE69231473T2 DE69231473T2 (de) | 2001-02-08 |
Family
ID=27123501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231473T Expired - Fee Related DE69231473T2 (de) | 1991-12-20 | 1992-12-21 | Immunochemischer nachweiss von endprodukten der fortgeschrittenen glycosylation in vivo |
Country Status (12)
Country | Link |
---|---|
US (6) | US5624804A (de) |
EP (1) | EP0623216B1 (de) |
JP (1) | JPH07502534A (de) |
KR (1) | KR100257733B1 (de) |
CN (1) | CN1053964C (de) |
AT (1) | ATE196549T1 (de) |
AU (1) | AU681340B2 (de) |
CA (1) | CA2126209A1 (de) |
DE (1) | DE69231473T2 (de) |
ES (1) | ES2150936T3 (de) |
PT (1) | PT101147A (de) |
WO (1) | WO1993013421A1 (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869534A (en) * | 1992-05-21 | 1999-02-09 | The Picower Institute For Medical Research | Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
US7585512B1 (en) * | 1990-05-08 | 2009-09-08 | Thomas Jefferson University | Composition and method of using tumor cells |
US5624804A (en) * | 1991-12-20 | 1997-04-29 | The Rockefeller University | Immunochemical detection of In vivo advanced glycosylation end products |
AU712004B2 (en) * | 1993-03-11 | 1999-10-28 | Picower Institute For Medical Research, The | Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
US6410598B1 (en) | 1994-02-03 | 2002-06-25 | Michael P. Vitek | Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
WO1995020979A1 (en) * | 1994-02-03 | 1995-08-10 | The Picower Institute For Medical Research | Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
US5610076A (en) * | 1994-04-29 | 1997-03-11 | Alteon Inc. | Method for detecting hemoglobin advanced glycosylation endproducts |
US5744318A (en) * | 1994-12-30 | 1998-04-28 | Alteon Inc. | Monoclonal antibody for the detection of advanced glycosylation endproducts in biological samples |
AU693992B2 (en) * | 1994-12-30 | 1998-07-09 | Alteon Inc. | Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
US5853703A (en) * | 1995-01-18 | 1998-12-29 | The Picower Institute For Medical Research | Preventing and reversing the formation of advanced glycosylation endproducts |
US5811242A (en) * | 1995-10-24 | 1998-09-22 | Tokuyama Corporation | Marker and reagent for diabetes mellitus and diabetes mellitus complication |
US5811401A (en) * | 1995-11-30 | 1998-09-22 | The Picower Institute For Medical Research | Advanced glycosylation endproducts and methods of use therefor |
WO1997023783A1 (en) * | 1995-12-26 | 1997-07-03 | The Picower Institute For Medical Research | Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
AU1431397A (en) * | 1995-12-29 | 1997-07-28 | Alteon Inc. | 6-(n-carboxymethylamino)caproate, salts thereof and methods of use therefor |
US6033862A (en) * | 1996-10-30 | 2000-03-07 | Tokuyama Corporation | Marker and immunological reagent for dialysis-related amyloidosis, diabetes mellitus and diabetes mellitus complications |
US6380165B1 (en) * | 1997-09-19 | 2002-04-30 | The Picower Institute For Medical Research | Immunological advanced glycation endproduct crosslink |
US6721582B2 (en) | 1999-04-06 | 2004-04-13 | Argose, Inc. | Non-invasive tissue glucose level monitoring |
US6505059B1 (en) | 1998-04-06 | 2003-01-07 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
US7899518B2 (en) * | 1998-04-06 | 2011-03-01 | Masimo Laboratories, Inc. | Non-invasive tissue glucose level monitoring |
US6728560B2 (en) | 1998-04-06 | 2004-04-27 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
US20020091324A1 (en) * | 1998-04-06 | 2002-07-11 | Nikiforos Kollias | Non-invasive tissue glucose level monitoring |
CN2445326Y (zh) * | 2000-10-09 | 2001-08-29 | 刘永详 | 测定被糖化蛋白的免疫分析装置 |
ES2231601T3 (es) * | 2001-03-22 | 2005-05-16 | F. Hoffmann-La Roche Ag | Metodo para la seleccion de reactivos y componentes en fase solida en ensayos de union especifica libres de productos finales de glicosilacion avanzados. |
MY140679A (en) | 2001-05-24 | 2010-01-15 | Avanir Pharmaceuticals | Inhibitors of macrohage migration inhibitory factor and methods for identifying the same |
GB0221686D0 (en) * | 2002-09-19 | 2002-10-30 | Univ Ulster | Biomarker |
TW200418829A (en) * | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
CN1839133A (zh) * | 2003-08-22 | 2006-09-27 | 阿文尼尔药品公司 | 作为巨噬细胞移动抑制因子的抑制剂的取代的二氮杂萘衍生物及其在治疗人类疾病中的应用 |
CN100489526C (zh) * | 2004-01-16 | 2009-05-20 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种人脑红蛋白检测及诊断试剂盒,其制备方法及用途 |
US20060229314A1 (en) * | 2005-03-24 | 2006-10-12 | Jagadish Sircar | Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
GB0605689D0 (en) * | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
US8216847B2 (en) * | 2006-03-24 | 2012-07-10 | Metanomics Gmbh | Means and method for predicting diabetes |
DE102006026173A1 (de) * | 2006-06-06 | 2007-12-20 | Fachhochschule Südwestfalen | Verfahren zur nichtinvasiven Diagnose von Diabetes |
JP2011521009A (ja) * | 2008-05-23 | 2011-07-21 | シワ コーポレイション | 再生を促進させる方法、組成物及び装置 |
US9060687B2 (en) | 2009-10-02 | 2015-06-23 | Sharp Kabushiki Kaisha | Device for monitoring blood vessel conditions and method for monitoring same |
WO2011114578A1 (ja) * | 2010-03-19 | 2011-09-22 | シャープ株式会社 | 測定装置および測定方法、ならびに、測定結果処理装置、測定システム、測定結果処理方法、制御プログラムおよび記録媒体 |
US9649376B2 (en) | 2010-09-27 | 2017-05-16 | Siwa Corporation | Selective removal of age-modified cells for treatment of atherosclerosis |
US8721571B2 (en) | 2010-11-22 | 2014-05-13 | Siwa Corporation | Selective removal of cells having accumulated agents |
KR101939401B1 (ko) | 2011-11-10 | 2019-01-16 | 가천대학교 산학협력단 | 단핵식세포계 세포의 age-알부민 합성 또는 분비 저해제를 유효성분으로 포함하는 허혈성 심장질환 예방 또는 치료용 조성물 |
IL251210B2 (en) * | 2014-09-19 | 2023-12-01 | Siwa Corp | Anti-aging antibodies for the treatment of inflammation and autoimmune disorders |
US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
AU2016336959A1 (en) * | 2015-10-13 | 2018-04-12 | Siwa Corporation | Anti-age antibodies and methods of use thereof |
JP6553491B2 (ja) * | 2015-11-26 | 2019-07-31 | オリエンタル酵母工業株式会社 | 最終糖化産物(AGEs)が関連する疾患の罹患又はそのリスクを予測する方法 |
ES2912064T3 (es) * | 2016-02-19 | 2022-05-24 | Siwa Corp | Método y composición para tratar el cáncer, destruir las células cancerosas metastásicas y evitar la metástasis del cáncer usando anticuerpo para productos finales de glicación avanzada (AGE) |
CN109311975A (zh) | 2016-04-15 | 2019-02-05 | Siwa有限公司 | 用于治疗神经退行性紊乱的抗age抗体 |
US11213585B2 (en) | 2016-06-23 | 2022-01-04 | Siwa Corporation | Vaccines for use in treating various diseases and disorders |
US10925937B1 (en) | 2017-01-06 | 2021-02-23 | Siwa Corporation | Vaccines for use in treating juvenile disorders associated with inflammation |
US10961321B1 (en) | 2017-01-06 | 2021-03-30 | Siwa Corporation | Methods and compositions for treating pain associated with inflammation |
US10858449B1 (en) | 2017-01-06 | 2020-12-08 | Siwa Corporation | Methods and compositions for treating osteoarthritis |
US10995151B1 (en) | 2017-01-06 | 2021-05-04 | Siwa Corporation | Methods and compositions for treating disease-related cachexia |
CN106769349B (zh) * | 2017-01-06 | 2020-01-21 | 上海君联医疗设备有限公司 | 血液中异常糖基化蛋白细胞的检测方法 |
US10919957B2 (en) | 2017-04-13 | 2021-02-16 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody |
EP3619540A1 (de) | 2017-05-04 | 2020-03-11 | Siwa Corporation | Diagnostische advanced-glycation-endproduct-antikörper |
US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
CN108776131B (zh) * | 2018-03-19 | 2020-06-09 | 深圳市南山区疾病预防控制中心 | 一种食品中AGEs含量的检测方法 |
WO2020023532A1 (en) | 2018-07-23 | 2020-01-30 | Siwa Corporation | Methods and compositions for treating chronic effects of radiation and chemical exposure |
WO2020041625A1 (en) | 2018-08-23 | 2020-02-27 | Siwa Corporation | Anti carboxymethyl lysine antibodies and ultrasound for removing age-modified cells |
CN111040001B (zh) * | 2019-12-27 | 2021-04-16 | 山西医科大学 | 安定代谢物葡萄糖醛酸结合物的制备方法 |
CN115996954A (zh) | 2020-05-01 | 2023-04-21 | Siwa有限公司 | 治疗感染的方法 |
WO2022093195A1 (en) | 2020-10-27 | 2022-05-05 | Siwa Corporation | Methods and compositions for treating osteoarthritis using anti-age antibodies or age antigens |
US20240000930A1 (en) | 2020-12-09 | 2024-01-04 | Siwa Corporation | Methods and compositions for treating kidney diseases |
WO2023023654A1 (en) | 2021-08-20 | 2023-02-23 | Siwa Corporation | Methods and compositions for treating fibrotic diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3654090A (en) * | 1968-09-24 | 1972-04-04 | Organon | Method for the determination of antigens and antibodies |
NL154598B (nl) * | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US4016043A (en) * | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
US4867973A (en) * | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
JPH0766253B2 (ja) * | 1986-06-20 | 1995-07-19 | 松下電器産業株式会社 | マトリクス型画像表示装置 |
AU600306B2 (en) * | 1986-09-12 | 1990-08-09 | Rockefeller University, The | Methods and agents for removing advanced glycosylation endproducts |
DE3882855T2 (de) * | 1987-09-17 | 1994-03-24 | Rockefeller University New Yor | Glycosylierte Endstoffe und damit verbundene Verfahren. |
US5223392A (en) * | 1988-01-25 | 1993-06-29 | Exocell, Inc. | Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore |
US5624804A (en) * | 1991-12-20 | 1997-04-29 | The Rockefeller University | Immunochemical detection of In vivo advanced glycosylation end products |
-
1992
- 1992-10-01 US US07/956,849 patent/US5624804A/en not_active Expired - Lifetime
- 1992-12-18 PT PT101147A patent/PT101147A/pt not_active Application Discontinuation
- 1992-12-19 CN CN92115235A patent/CN1053964C/zh not_active Expired - Fee Related
- 1992-12-21 CA CA002126209A patent/CA2126209A1/en not_active Abandoned
- 1992-12-21 JP JP5511864A patent/JPH07502534A/ja active Pending
- 1992-12-21 KR KR1019940702138A patent/KR100257733B1/ko not_active IP Right Cessation
- 1992-12-21 AU AU34187/93A patent/AU681340B2/en not_active Ceased
- 1992-12-21 ES ES93902713T patent/ES2150936T3/es not_active Expired - Lifetime
- 1992-12-21 WO PCT/US1992/011158 patent/WO1993013421A1/en active IP Right Grant
- 1992-12-21 DE DE69231473T patent/DE69231473T2/de not_active Expired - Fee Related
- 1992-12-21 AT AT93902713T patent/ATE196549T1/de not_active IP Right Cessation
- 1992-12-21 EP EP93902713A patent/EP0623216B1/de not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/487,055 patent/US5683887A/en not_active Expired - Lifetime
- 1995-06-07 US US08/476,381 patent/US5629408A/en not_active Expired - Lifetime
- 1995-06-07 US US08/472,398 patent/US5712101A/en not_active Expired - Fee Related
- 1995-06-07 US US08/484,869 patent/US5733546A/en not_active Expired - Fee Related
- 1995-06-07 US US08/486,513 patent/US5702704A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5629408A (en) | 1997-05-13 |
AU681340B2 (en) | 1997-08-28 |
PT101147A (pt) | 1994-03-31 |
WO1993013421A1 (en) | 1993-07-08 |
ES2150936T3 (es) | 2000-12-16 |
AU3418793A (en) | 1993-07-28 |
EP0623216A1 (de) | 1994-11-09 |
CN1079825A (zh) | 1993-12-22 |
JPH07502534A (ja) | 1995-03-16 |
US5683887A (en) | 1997-11-04 |
KR100257733B1 (ko) | 2000-06-01 |
US5733546A (en) | 1998-03-31 |
EP0623216B1 (de) | 2000-09-20 |
DE69231473T2 (de) | 2001-02-08 |
CN1053964C (zh) | 2000-06-28 |
KR940704003A (ko) | 1994-12-12 |
ATE196549T1 (de) | 2000-10-15 |
CA2126209A1 (en) | 1993-07-08 |
US5712101A (en) | 1998-01-27 |
US5624804A (en) | 1997-04-29 |
US5702704A (en) | 1997-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69231473T2 (de) | Immunochemischer nachweiss von endprodukten der fortgeschrittenen glycosylation in vivo | |
SE8103759L (sv) | Blodkoagulationsbefremjande preparation basera pa humanproteiner liksom sett att framstella densamma | |
DE3685625T2 (de) | Antikoerperkomplexe von haptenmodifizierten diagnostischen oder therapeutischen mitteln. | |
SE8902377D0 (sv) | Foerfarande foer framstaellning av ett vaevnadsbindemedel | |
ATE239797T1 (de) | Antikörper gegen beta-amyloid oder derivative davon und seine verwendung | |
EE9600192A (et) | Antikehad, mis seostuvad putuka soole valkudele, ja nende kasutamine | |
DE69937899D1 (de) | Antikörper-serumprotein hybride | |
ATE132197T1 (de) | Monoklonale antikörper | |
SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
IT8483359A0 (it) | Procedimento per ottenere lapreparazione di concentrati e nutrimenti proteici dal sangue animale. | |
NL192456B (nl) | Humane eiwitten. | |
DE3478958D1 (en) | Protein conjugates of penicilloic acid, their preparation and use | |
DE3851007T2 (de) | Zusammensetzung zur Verwendung in der Landwirtschaft. | |
DE3881533D1 (de) | Tiermedizinische zusammensetzung zur verhinderung von diarrhoe bei tieren. | |
IT1136217B (it) | Macchina per la fienagione in particolare per il rivoltamento e l anda natura di fieno o foraggio | |
SE8502997D0 (sv) | Forfarande for framstellning av medicinska kosmetiska kompositioner | |
PT86944A (pt) | Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben | |
JPS58501543A (ja) | ヒトインタ−フエロン蛋白とヒトインタ−フエロン蛋白に対する抗体に関する改良 | |
ATE407944T1 (de) | Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz | |
DE69232975D1 (de) | Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung | |
BE870604A (fr) | Aliment proteique ayant une bonne cohesion | |
SE8002602L (sv) | Diagnostiskt forfarande | |
ES2067058T3 (es) | Tratamiento de carnes. | |
ATE125306T1 (de) | Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen. | |
ATE180167T1 (de) | Inhibition der ausscheidung von natrium durch die na-k-atpase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |